Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.

The FDA has issued traditional approval to Novartis for Fabhalta to slow the decline of kidney function in adults with primary IgAN who are at risk of disease progression.

MSD (Merck & Co) has won US Food and Drug Administration (FDA) approval for its cholesterol-lowering pill, marking a significant milestone in the drugmaker’s push to reduce revenue reliance on ...

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended a routine programme with the 4CMenB vaccine for adolescents.

The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement ...

Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for oral Wegovy (semaglutide). The European Commission (EC) granted m ...

With 89% of AI pilots failing to scale, biopharmas can move from data skepticism to advocacy by building a trusted, globally harmonized foundation.

AdvanCell will use the mega-round earnings to progress ADVC001 and build radiopharmaceutical manufacturing infrastructure.

From crude chemical and protein measurements to the advent of sophisticated precision medicine strategies, biomarkers are reshaping the future of nephrology research. This article charts the evolution ...